LONG COVID19

Clinical trials for LONG COVID19 explained in plain language.

Never miss a new study

Get alerted when new LONG COVID19 trials appear

Sign up with your email to follow new studies for LONG COVID19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1 Completed 10

Could a common Weight-Loss drug shield the brain? early trial launches

Knowledge-focused Terminated

This pilot study tests whether liraglutide (Saxenda), a weight-loss drug, can raise levels of a brain-protective protein called BDNF in 30 people with multiple sclerosis, long-COVID, or leukemia who are overweight and have memory or concentration problems. Participants will injec…

Matched conditions: LONG COVID19

Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused

Last updated Jun 27, 2026 12:01 UTC

LONG COVID19

Get alerted when new LONG COVID19 trials appear

Could a common Weight-Loss drug shield the brain? early trial launches